Publicaciones en colaboración con investigadores/as de University of California, San Francisco (6)

2022

  1. Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants

    Multiple Sclerosis and Related Disorders, Vol. 64

2021

  1. Artificial intelligence extension of the OSCAR-IB criteria

    Annals of Clinical and Translational Neurology, Vol. 8, Núm. 7, pp. 1528-1542

2020

  1. Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis

    Frontiers in Pediatrics, Vol. 8

2018

  1. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    The Lancet, Vol. 391, Núm. 10127, pp. 1263-1273

2016

  1. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: A cohort study

    The Lancet Neurology, Vol. 15, Núm. 6, pp. 574-584

2013

  1. Therapeutic decisions inmultiple sclerosis moving beyond efficacy

    JAMA Neurology, Vol. 70, Núm. 10, pp. 1315-1324